Quoin Pharmaceuticals Ltd - ADR

NASDAQ:QNRX   3:59:51 PM EDT
2.90
-0.37 (-11.32%)
Earnings Announcements

Quoin Pharmaceuticals Reports Quarterly Loss Per Share Per ADS Of $3.24

Published: 08/18/2022 11:25 GMT
Quoin Pharmaceuticals Ltd - ADR (QNRX) - Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2022 Financial Results.
Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2022 Financial Results.
Quoin Pharmaceuticals Ltd - Initiates Clinical Trial Evaluating Lead Product Candidate, Qrx003 for Netherton Syndrome.
Quoin Pharmaceuticals - Qtrly Loss per Share per Ads $3.24.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.35

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.16

More details on our Analysts Page.